BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38320260)

  • 1. Acetyllevocarnitine Hydrochloride for the Treatment of Diabetic Peripheral Neuropathy: A Phase 3 Randomized Clinical Trial in China.
    Guo L; Pan Q; Cheng Z; Li Z; Jiang H; Zhang F; Li Y; Qiu W; Lu S; Tian J; Fu Y; Li F; Li D
    Diabetes; 2024 May; 73(5):797-805. PubMed ID: 38320260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.
    Rolim LC; da Silva EM; Flumignan RL; Abreu MM; Dib SA
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011265. PubMed ID: 31201734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.
    Li S; Chen X; Li Q; Du J; Liu Z; Peng Y; Xu M; Li Q; Lei M; Wang C; Zheng S; Zhang X; Yu H; Shi J; Tao S; Feng P; Tian H
    J Diabetes Investig; 2016 Sep; 7(5):777-85. PubMed ID: 27180954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial.
    Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C
    Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial.
    Satoh J; Yagihashi S; Baba M; Suzuki M; Arakawa A; Yoshiyama T; Shoji S
    Diabet Med; 2011 Jan; 28(1):109-16. PubMed ID: 21166852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.
    Ziegler D; Hanefeld M; Ruhnau KJ; Hasche H; Lobisch M; Schütte K; Kerum G; Malessa R
    Diabetes Care; 1999 Aug; 22(8):1296-301. PubMed ID: 10480774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of oral prostaglandin analogue on painful diabetic neuropathy: a double-blind, randomized, controlled trial.
    Shin S; Kim KJ; Chang HJ; Lee BW; Yang WI; Cha BS; Choi D
    Diabetes Obes Metab; 2013 Feb; 15(2):185-8. PubMed ID: 22974254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor.
    Kessler JA; Shaibani A; Sang CN; Christiansen M; Kudrow D; Vinik A; Shin N;
    Clin Transl Sci; 2021 May; 14(3):1176-1184. PubMed ID: 33465273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial.
    Arezzo JC; Rosenstock J; Lamoreaux L; Pauer L
    BMC Neurol; 2008 Sep; 8():33. PubMed ID: 18796160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.
    Hotta N; Toyota T; Matsuoka K; Shigeta Y; Kikkawa R; Kaneko T; Takahashi A; Sugimura K; Koike Y; Ishii J; Sakamoto N;
    Diabetes Care; 2001 Oct; 24(10):1776-82. PubMed ID: 11574441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect and Safety of Herbal Medicine Foot Baths in Patients with Diabetic Peripheral Neuropathy: A Multicenter Double-Blind Randomized Controlled Trial.
    Huang HY; Lin YP; Wei H; Fu Y; Zhou YH; Fang ZH; Qiu XT; Wang M; Li QB; Li SS; Wang SD; Dai F; Liu ZJ; Zhao L; Wen JX; Wu LY; Zeng HY; Zhang JM; Lu QY; He L; Song W; Sun L; Luo LL; He JL; Xie WW; Liang QS; Huang Y; Zhu SL; Long JE; Gao ZJ; Wen ZH; Li CJ; Ouyang WW; Li G; Wu MH; Li AX; Huang JZ; Paul SK; Tang XY; Fan GJ
    Chin J Integr Med; 2024 Mar; 30(3):195-202. PubMed ID: 38374490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of pregabalin for painful diabetic peripheral neuropathy in a population of Chinese patients: A randomized placebo-controlled trial.
    Mu Y; Liu X; Li Q; Chen K; Liu Y; Lv X; Xu X; Fan D; Shang N; Yang R; Pauer L; Pan C
    J Diabetes; 2018 Mar; 10(3):256-265. PubMed ID: 28727270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy.
    Rauck R; Makumi CW; Schwartz S; Graff O; Meno-Tetang G; Bell CF; Kavanagh ST; McClung CL
    Pain Pract; 2013 Jul; 13(6):485-96. PubMed ID: 23186035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial.
    Wahren J; Foyt H; Daniels M; Arezzo JC
    Diabetes Care; 2016 Apr; 39(4):596-602. PubMed ID: 26884473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Low Doses of Trazodone in Patients Affected by Painful Diabetic Neuropathy and Treated with Gabapentin: A Randomized Controlled Pilot Study.
    Lipone P; Ehler E; Nastaj M; Palka-Kisielowska I; Cruccu G; Truini A; Di Loreto G; Del Vecchio A; Pochiero I; Comandini A; Calisti F; Cattaneo A
    CNS Drugs; 2020 Nov; 34(11):1177-1189. PubMed ID: 32936427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study.
    Raskin P; Huffman C; Yurkewicz L; Pauer L; Scavone JM; Yang R; Parsons B
    Clin J Pain; 2016 Mar; 32(3):203-10. PubMed ID: 25968451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy.
    Vinik AI; Shapiro DY; Rauschkolb C; Lange B; Karcher K; Pennett D; Etropolski MS
    Diabetes Care; 2014 Aug; 37(8):2302-9. PubMed ID: 24848284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients.
    Baba M; Matsui N; Kuroha M; Wasaki Y; Ohwada S
    J Diabetes Investig; 2019 Sep; 10(5):1299-1306. PubMed ID: 30672128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Randomized, Double-Blind Study of the Effects of a Sustained Release Formulation of Sodium Nitrite (SR-nitrite) on Patients with Diabetic Neuropathy.
    Soin A; Bock G; Giordano A; Patel C; Drachman D
    Pain Physician; 2018 Mar; 21(2):179-190. PubMed ID: 29565948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.